CARDIFF ONCOLOGY, INC. (CRDF) Shareholders’ equity 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) shareholders’ equity at each fiscal year-end, per SEC filings.
$45.4MFY2025 · since FY2016: $19.8M → $45.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $45.4M | -45.3% |
| FY2024 | $82.9M | +18.9% |
| FY2023 | $69.7M | -34.4% |
| FY2022 | $106.3M | -24.3% |
| FY2021 | $140.4M | +9.6% |
| FY2020 | $128.2M | +1652.7% |
| FY2019 | $7.3M | -27.5% |
| FY2018 | $10.1M | +55.0% |
| FY2017 | $6.5M | -67.1% |
| FY2016 | $19.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice